The tuberculosis vaccine pipeline
30 June 2013. Related: Pipeline report, Special reports, TB coinfection, Vaccines and microbicides
HIV Treatment Bulletin
Vaccines and microbicides
Herpes Zoster vaccine safe and effective in HIV positive people
1 April 2012. Related: Conference reports, Vaccines and microbicides , CROI 19 (Retrovirus) 2012
High dose flu vaccine improves antibody responses in HIV positive people
1 April 2012. Related: Conference reports, Vaccines and microbicides , CROI 19 (Retrovirus) 2012
Preventive technologies, immune-based and gene therapies, and research towards a cure
14 July 2011. Related: Basic science and immunology, Transmission and prevention, Vaccines and microbicides
Results from the Caprisa 004 tenofovir microbicide trial
26 August 2010. Related: Conference reports, Transmission and prevention, Vaccines and microbicides , World AIDS 18 Vienna 2010
Quadrivalent HPV vaccine reduces genital lesions and HPV acquisition in men
26 August 2010. Related: Conference reports, Transmission and prevention, Vaccines and microbicides , World AIDS 18 Vienna 2010
Immune-based therapies and preventive technologies pipeline
1 July 2010. Related: Basic science and immunology, Transmission and prevention, Vaccines and microbicides
PRO 2000 microbicide gel does not pan out
3 February 2010. Related: Vaccines and microbicides
Thai HIV Vaccine Trial results presented and published
31 December 2009. Related: Conference reports, Vaccines and microbicides , AIDS Vaccine 9 Paris 2009
The role of Ad5-specific CD4 T-cells in enhancing risk of HIV acquisition in the Merck vaccine trial
22 August 2009. Related: Basic science and immunology, Vaccines and microbicides
US cancel Phase 3 HIV vaccine trial
30 October 2008. Related: Basic science and immunology, Vaccines and microbicides
Microbial translocation in immunological non-responders to ART
30 October 2008. Related: Basic science and immunology, Vaccines and microbicides
A surreal, deeply troubling week for AIDS vaccine research
1 June 2008. Related: Basic science and immunology, Vaccines and microbicides
Merck HIV vaccine trial is unblinded
1 December 2007. Related: Vaccines and microbicides
Merck HIV vaccine trial halted by DSMB for lack of efficacy
2 October 2007. Related: Vaccines and microbicides
Royalty-free license granted for development of tenofovir and topical microbicide
5 February 2007. Related: Treatment access, Vaccines and microbicides
Two Phase III HIV microbicide trials stopped due to increased transmission
5 February 2007. Related: Vaccines and microbicides
Topical microbicides: the real front line of HIV prevention
12 May 2006. Related: Conference reports, Transmission and prevention, Vaccines and microbicides , CROI 13 (Retrovirus) 2006
Keystone vaccine symposia 2005: vaccines, pathogenesis, snow and a couple of elk
14 August 2005. Related: Conference reports, Vaccines and microbicides , Conference index
Human Papilloma Virus vaccines a review of advances in the development of HPV vaccines
14 July 2005. Related: Special reports, Vaccines and microbicides
Keystone HIV Pathogenesis and Vaccine Report
29 July 2004. Related: Basic science and immunology, Conference reports, Vaccines and microbicides , Keystone pathogenesis 2004
VaxGen AIDSVAX vaccine fails in Thailand
1 December 2003. Related: Vaccines and microbicides
Vaccine research: Can DNA vaccines get a boost from cytokines?
1 July 2003. Related: On the web, Vaccines and microbicides
HIV vaccine symposium: more questions than answers
1 June 2003. Related: Vaccines and microbicides
Pushing the envelope: a new dawn for the role of antibodies in immune control of HIV?
1 June 2003. Related: Vaccines and microbicides
Vaxgen announces disappointing results from first large international vaccine trial
1 April 2003. Related: Vaccines and microbicides
GMHC criticises Vaxgen for obfuscation of trial results of its AIDS vaccine
1 April 2003. Related: Vaccines and microbicides
Behind the headlines about vaccine research
11 September 2002. Related: Conference reports, Vaccines and microbicides , World AIDS 14 Barcelona 2002
Trials of Immune Response Corp’s AIDS vaccine Remune may end after Pfizer drops financial support
1 September 2001. Related: Vaccines and microbicides
Basis of HIV resistance suggests new vaccine strategy
30 July 2001. Related: Basic science and immunology, Vaccines and microbicides
Immune Response Corporation tried to block report on failure of Remune
17 December 2000. Related: Vaccines and microbicides
United Kingdom authorities clear AIDS vaccine for human testing
17 October 2000. Related: Vaccines and microbicides
Murabutide inhibits HIV replication in macrophages and dendritic cells
16 September 2000. Related: Vaccines and microbicides
NIH suspends enrolment in Remune study
16 July 2000. Related: Vaccines and microbicides